Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease

References

• Embury SH, Hebbel RP, Mohandas N, et al. editors. Sickle cell disease: basic principles and clinical practice. New York, NY: Raven Press; 1994.
   Google Scholar
• Serjeant GR, Serjeant BE. Sickle cell disease. Oxford, UK: Oxford University Press; 2001.
   Google Scholar
• El-Hazmi MA, Al-Hazmi AM, Warsy AS. Sickle cell disease in middle East Arab countries. Indian J Med Res. 2011;134:597–610. doi: 10.4103/0971-5916.90984
   PubMedGoogle Scholar
• El-Hazmi MA, Warsy AS. Hemoglobinopathies in Arab countries. In: Teebi AS, Farag TL, editors. Genetic disorders among Arab populations. New York: Oxford University Press; 1997. p. 83 –110.
   Google Scholar
• Marouf RA, D’souza TM, Adekile AD. Hemoglobin electrophoresis and hemoglobinopathies in Kuwait. Med Princ Pract. 2002;11:38–41. doi: 10.1159/000048659
   PubMed Web of Science ®Google Scholar
• Wilson WA, Thomas EJ, Sissons JGP. Complement activation in asymptomatic patients with sickle cell anaemia. Clin Exp Immunol. 1979;36:130–139.
   PubMed Web of Science ®Google Scholar
• Chudwin DS, Korenblit AD, Kingzette M, et al. Increased activation of the alternative complement pathway in sickle cell disease. Clin Immunol Immunopathol. 1985;37:93–97. doi: 10.1016/0090-1229(85)90139-4
   PubMedGoogle Scholar
• Bensinger TA, Gillette PN. Hemolysis in sickle cell disease. Arch Intern Med. 1974;133:624–631. doi: 10.1001/archinte.1974.00320160118010
   PubMedGoogle Scholar
• Meri S, Jarva H. Complement regulation. Vox Sang. 1998;74(Suppl. 2):291–302. doi: 10.1111/j.1423-0410.1998.tb05434.x
   PubMed Web of Science ®Google Scholar
• Nicholsen-Weller A, March JP, Rosenfeld SI, et al. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci. 1983;80:5066–5070. doi: 10.1073/pnas.80.16.5066
   PubMed Web of Science ®Google Scholar
• Holguin MH, Frederick LR, Bernshaw NJ, et al. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1989;84:7–17. doi: 10.1172/JCI114172
   PubMed Web of Science ®Google Scholar
• Alfnito F, Del Vecchio L, Rocco S, et al. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone. Leukemia. 1996;10:1326–1330.
   PubMed Web of Science ®Google Scholar
• Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332–5340.
   PubMed Web of Science ®Google Scholar
• Blanchard D, Navenot JM, Petit Le Roux Y, et al. Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins. Transfus Clin Biol. 1997;4:131–134. doi: 10.1016/S1246-7820(97)80028-6
   PubMed Web of Science ®Google Scholar
• Nebe CT. Paroxysmal Nocturnal Hemoglobinuria: clinical aspects and flow cytometric analysis. In: Gutensohn K, Sonneborn H-H, Kühnl P, editors Aspects of the flow-cytometric analysis of red blood cells. Mainz, Germany: Clin Lab Publications; 1997. p. 81–94.
   Google Scholar
• Yamamoto M, Figueiredo MS, Bahia DM. Evaluation of paroxysmal nocturnal hemoglobinuria clone in peripheral blood cells using flow cytometry technique. Blood. 1999;94(Suppl. 2), A 3177–3178.
   PubMed Web of Science ®Google Scholar
• Frank MM. Complement in the pathophysiology of human disease. N Engl J Med. 1987;316:1525–1530. doi: 10.1056/NEJM198706113162407
   PubMed Web of Science ®Google Scholar
• Lublin DM, Atkinson JP. Decay accelerating factor: biochemistry, molecular biology and function. Ann Rev Immunol. 1989;7:35–58. doi: 10.1146/annurev.iy.07.040189.000343
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement: first of two parts. N Engl J Med. 2001;344:1058–1066. doi: 10.1056/NEJM200104053441406
   PubMed Web of Science ®Google Scholar
• Allan D, Limbrick AR, Thomas P, et al. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature. 1982;295:612–613. doi: 10.1038/295612a0
   PubMed Web of Science ®Google Scholar
• Wagner GM, Chiu DTY, Yee MC, et al. Red cell vesiculation-A common membrane physiologic event. J Lab Clin Med. 1986;108:315–324.
   PubMed Web of Science ®Google Scholar
• Biitikofer P, Kuypers FA, Xu CM, et al. Enrichment of two glycosyl-phosphatidylinositol-anchored proteins, acetylcholinesterase and decay-accelerating factor, in vesicles released from human red blood cells. Blood. 1989;74:1481–1485.
   PubMed Web of Science ®Google Scholar
• Test ST, Biitikofer P, Yee MC, et al. Characterization of the complement sensitivity of calcium loaded human erythrocytes. Blood. 1991;78:3056–3065.
   PubMed Web of Science ®Google Scholar
• Meletis J, Terpos E. Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria. Med Sci Monit. 2003;9:RA161–RA172.
   PubMedGoogle Scholar
• Ruiz-Delgado GJ, Vázquez-Garza E, Méndez-Ramírez N, et al. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria. Hematology. 2009;14:33–37. doi: 10.1179/102453309X385089
   PubMed Web of Science ®Google Scholar
• Barros MM, Yamamoto M, Figueiredo MS, et al. Expression levels of CD47, CD35, CD55, and CD59 on red blood cells and signal-regulatory protein on monocytes from patients with warm autoimmune hemolytic anemia. Transfusion. 2009;49:154–160. doi: 10.1111/j.1537-2995.2008.01936.x
   PubMed Web of Science ®Google Scholar
• Terpos E, Sarantopoulos A, Kouramba A, et al. Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection. Med Sci Monit. 2008;14:CR276–CR280.
   PubMed Web of Science ®Google Scholar
• Ma XW, Chang ZW, Qin MZ, et al. Decreased expression of complement regulatory proteins, CD55 and CD59, on peripheral blood leucocytes in patients with type 2 diabetes and macrovascular diseases. Chin Med J. 2009;122:2123–2128.
   PubMed Web of Science ®Google Scholar
• Alegretti AP, Mucenic T, Merzoni J, et al. Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients. Cell Immunol. 2010;265:127–132. doi: 10.1016/j.cellimm.2010.07.013
   PubMed Web of Science ®Google Scholar
• Xu WD, Zhang YJ, Zhou M, et al. Reduced expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus: profitable to diagnose some complications? Cell Immunol. 2011;271:15–17. doi: 10.1016/j.cellimm.2011.06.024
   PubMed Web of Science ®Google Scholar
• Salama MA, Sadek NA, Hassab HM, et al. Erythrocyte autoantibodies and expression of CD59 on the surface of red blood cells of polytransfused patients with beta-thalassaemia major. Br J Biomed Sci. 2004;61:88–92. doi: 10.1080/09674845.2004.11732650
   PubMed Web of Science ®Google Scholar
• Ohi H, Tamano M, Sudo S, et al. Recombinant EPO therapy increases erythrocyte expression of complement regulatory proteins. Am J Kidney Dis. 2003;41:179–185. doi: 10.1053/ajkd.2003.50002
   PubMed Web of Science ®Google Scholar
• Qari MH, Dier U, Mousa SA. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease. Clin Appl Thromb Hemost. 2012;18:195–200. doi: 10.1177/1076029611420992
   PubMed Web of Science ®Google Scholar
• Test ST, Woolworth VS. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation. Blood. 1994;l83:842–852.
   Google Scholar
• Hebbel RP. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood. 1991;177:214–237.
   Google Scholar
• Borowitz MJ, Craig FE, Digiuseppe JA, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2010;78:211–230.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Keeney M, Illingworth A. Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry. Cytometry B Clin Cytom. 2012;82(4):195–208. doi: 10.1002/cyto.b.21023
   PubMed Web of Science ®Google Scholar
• Ataga KI, Moore CG, Hillery CA, et al. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica. 2008;93:20–26. doi: 10.3324/haematol.11763
   PubMed Web of Science ®Google Scholar
• Etienne-Julan M, Belloy MS, Decastel M, et al. Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin. Haematologica. 2004;89:863–864.
   PubMed Web of Science ®Google Scholar